Fennec Pharmaceuticals Inc. SEC filings FENC
Fennec Pharmaceuticals Inc. has 853 filings in SEC EDGAR's recent list, going back to Dec 10, 2002. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 10, 2026 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 3, 2025 |
| DEF 14A | Proxy statement | May 13, 2024 | Jun 25, 2024 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 12, 2023 |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 14, 2022 |
| DEF 14A | Proxy statement | May 25, 2021 | Jun 29, 2021 |
| DEF 14A | Proxy statement | May 11, 2020 | Jun 22, 2020 |
| DEF 14A | Proxy statement | May 16, 2019 | Jun 18, 2019 |
| DEF 14A | Proxy statement | May 10, 2018 | Jun 7, 2018 |
| DEF 14A | Proxy statement | May 24, 2017 | Jun 27, 2017 |
| DEF 14A | Proxy statement | May 12, 2016 | Jun 8, 2016 |
| DEF 14A | Proxy statement | May 5, 2015 | May 28, 2015 |
| DEF 14A | Proxy statement | May 6, 2014 | May 28, 2014 |
| DEF 14A | Proxy statement | May 24, 2013 | Jun 18, 2013 |
| DEF 14A | Proxy statement | May 21, 2012 | Jun 12, 2012 |
| DEF 14A | Proxy statement | Jun 7, 2011 | Jun 28, 2011 |
| DEF 14A | Proxy statement | Jun 2, 2010 | Jun 24, 2010 |
| DEF 14A | Proxy statement | Apr 1, 2009 | May 19, 2009 |
| DEF 14A | Proxy statement | Mar 28, 2008 | May 14, 2008 |
| DEF 14A | Proxy statement | Apr 3, 2007 | Apr 27, 2007 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- FENC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Research Triangle Park, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1211583
- Former names
- ADHEREX TECHNOLOGIES INC (until Aug 14, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.